Risk communication with Reinerio A. Deza #drugsafety

Reinerio A. Deza, MD, Head Global Pharmacovigilance, Cubist Pharmaceuticals spoke at the World Drug Safety Congress Americas last month on Risk Communication. He explained the purpose of risk communication as providing information regarding the positive and negative effects of a product to the intended user. He then went on to describes the process that takes place from identification through to …